• Profile
Close

Nasal high‐flow oxygen vs conventional oxygen therapy for acute severe asthma patients: A pilot randomized controlled trial

Academic Emergency Medicine May 24, 2021

Ruangsomboon O, Limsuwat C, Praphruetkit N, et al. - Via this pilot nonblinded randomized controlled trial, an attempt was made to compare the efficacy of nasal high flow (NHF) vs conventional oxygen therapy (COT) for improving dyspnea in acute severe asthma patients experiencing hypoxemia in the emergency department (ED). A total of 37 such patients aged ≥ 18 years were included and randomly assigned to undergo either COT (n = 18) or NHF (n = 19) for 120 minutes. A reduction in the severity of dyspnea and respiratory rate was shown to be conferred by nasal high flow in this study population of hypoxemic patients with acute severe asthma in the ED.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay